|Bremer Tageszeitungen AG||-|
|CAPNOVA||Aarhus, Denmark, Midtjylland|
|Centre for Commercialization of Regenerative Medicine||Canada, Ontario, Toronto|
|Disruptive Technologies||Bergen, Hordaland, Norway|
|Galvanise Capital||England, London, United Kingdom|
|Goodbye Kansas Game Invest||Stockholm, Stockholm County, Sweden|
|Griffith Foods||Alsip, Illinois, United States|
|Guohong Zhisheng Venture Capital||China, Shanghai|
|Kohlberg Ventures||California, Portola Valley, United States|
|Mentor Capital Partners||Pennsylvania, United States, Yardley|
|Nanchang Daxue Kejiyuan Development||China, Guangdong, Jiangxi|
|Nippon Television Holdings||Japan, Tokyo|
|POCKET CARD||Japan, Tokyo|
|Port of Amsterdam||-|
|Schroders||England, London, United Kingdom|
|Trammell Ventures||Austin, Texas, United States|
|$11M||16 May 2022||Genk, Limburg, Belgium|
|$14M||21 Jan 2021||Leuven, Flemish Brabant, Belgium|
|$23M||19 Apr 2016||North Holland|
– Kebony is a Oslo, Norway-based environmentally friendly wood modification technology company.
– The company raised €30m in funding.
– The round was led by Jolt Capital and Lightrock with participation from existing shareholders such as Goran, MVP, FPIM, PMV and Investinor.
– The new investment will be used to accelerate growth initiatives in core markets in Europe and the US.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.